EDMOND DE ROTHSCHILD HOLDING S.A. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$10,000
+25.0%
2,2000.0%0.00%
Q4 2018$8,000
-63.6%
2,2000.0%0.00%
-100.0%
Q3 2018$22,000
+37.5%
2,2000.0%0.00%
Q2 2018$16,000
+23.1%
2,2000.0%0.00%
Q1 2018$13,000
-38.1%
2,2000.0%0.00%
-100.0%
Q4 2017$21,000
+5.0%
2,2000.0%0.00%0.0%
Q3 2017$20,000
-28.6%
2,2000.0%0.00%0.0%
Q2 2017$28,000
+21.7%
2,2000.0%0.00%0.0%
Q1 2017$23,000
+15.0%
2,2000.0%0.00%0.0%
Q4 2016$20,000
-4.8%
2,200
+193.3%
0.00%0.0%
Q4 2015$21,0007500.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders